evolcSign inStart free
Menu

Immutrin

Develops antibody therapies to remove amyloid deposits for people with amyloidosis, including ATTR cardiomyopathy

Cambridge, United KingdomFounded 2019immutrin.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-07

About Immutrin

Immutrin is a biotechnology company developing antibody therapies intended to deplete systemic amyloid deposits and reverse amyloidosis. Its lead asset is being developed for ATTR cardiomyopathy.

The company was co-founded by Cambridge Innovation Capital and academic founders Mark Pepys, Gregory Winter and Daniel Christ. It is based in Cambridge, United Kingdom, and announced a Series A financing in March 2026.

Product: Antibody therapy in development to remove established amyloid fibrils and treat amyloidosis.

Jobs at Immutrin

No open positions listed right now.

More biotech & pharma companies

  • IMU Biosciences

    Immune profiling and precision-medicine tools for clinical research, pharmaceutical, biotech and diagnostics organizations
    United KingdomBiotech & pharma1 open job
    Remote-friendly

  • Infectopharm

    Pharmaceutical products for healthcare providers and distribution partners in the UK market
    Marlow, United KingdomBiotech & pharmaFounded 2024
    Young companyNew on Evolc

  • Infinitopes

    Develops off-the-shelf precision cancer vaccines for cancer patients, using tumour-specific targets and engineered viral vectors
    Oxford, United KingdomBiotech & pharmaFounded 2021
    New on Evolc

  • Ingenza

    Biotechnology CRDMO developing and manufacturing biologics, pharmaceuticals and industrial products for companies
    Edinburgh Technopole, United KingdomBiotech & pharmaFounded 20023 open jobs
    New on Evolc

  • Inovia Bio

    Drug-development strategy, evidence generation and AI platforms for biotech and pharma development teams, priced per outcome
    London, United KingdomBiotech & pharmaFounded 2022
    Young companyNew on Evolc

  • Invibio

    Implant-grade PEEK polymers and biomaterial solutions for medical device manufacturers
    Cleveleys, United KingdomBiotech & pharmaFounded 2000
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.